Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-13

Clinical Trial Update: Fracture Recovery for Returning to Duty (Teriparatide STRONG) [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating teriparatide for stress fractures of the tibia or fibula in returning-to-duty scenarios.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Teriparatide)

Snippet

Sponsor: University of South Carolina | Conditions: Stress Fracture of Tibia or Fibula | Phase 4 | Status: ENROLLING_BY_INVITATION